MAX-40279

· Maxinovel Pty., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MAX-40279, covering 2022-06-21 to 2022-06-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MAX-40279combined With KN046 in Patients With Advanced / Metastatic Solid Tumors [Phase 1, Phase 2]